Magnesium L-threonate (often sold under the brand name Magtein) is marketed specifically for the brain, on the strength of a 2010 rodent study showing it raised brain magnesium and improved learning and memory in rats. That is genuinely interesting mechanism work, but it is preclinical. The human safety and efficacy picture rests on much thinner ground, and it is worth understanding before you start, especially since this form is priced at a premium over ordinary magnesium.

This article is educational and is not medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a qualified clinician before starting anything new, especially if you take medication or have a health condition.

The short version

The first human trial, a randomized, placebo-controlled study in older adults with cognitive complaints, reported the compound as generally well tolerated over about 12 weeks. Two newer randomized trials in adults with self-reported sleep problems followed in 2024 and 2026, but all three are small and commercially funded, and none has been replicated by an independent group, which is a narrow base to generalize "safe" from. By our evidence standards, magnesium L-threonate's cognition claim is graded C: a modest signal in small, commercially funded trials, without independent replication, and a publicly funded 2023 trial in patients after breast-cancer surgery found no significant sleep or cognitive difference from placebo.

Side effects reported

  • Generally well tolerated in the available trial data.
  • Headache or drowsiness: reported occasionally.
  • GI upset or loose stools: reported less often than with magnesium oxide or citrate, which are more classically laxative forms.

That is a fairly quiet side-effect list, but it comes from a few small, short trials plus general clinical experience with magnesium as a mineral class, not a large, dedicated safety program for this specific compound.

The elemental-magnesium labeling issue

This is the single most common way magnesium L-threonate gets oversold, and it matters for both dosing and side effects. The human trial used roughly 1.5–2 g per day of magnesium L-threonate as a compound, but that delivers a relatively small amount of actual (elemental) magnesium, because threonate is a large carrier molecule. A label that states only the compound weight, without disclosing elemental magnesium per serving, makes it impossible to tell whether you are getting a meaningfully different total-magnesium dose than a cheaper form.

  • Always look for elemental magnesium stated per serving, not just "magnesium L-threonate" weight.
  • For general magnesium repletion rather than the brain-specific rationale, glycinate or citrate deliver more elemental magnesium per dose and cost less.
  • Health Canada's magnesium monographs cover mineral, electrolyte, and bone/muscle roles, not cognition, so a brain-specific claim sits outside the monograph pathway and should be read as the manufacturer's own framing, not a regulator-recognized benefit.

Building a cleaner stack? The Clean Focus Stack Guide is free when you join the Signal State waitlist. Get the guide

Who should check with a clinician first

  • Kidney impairment: reduced magnesium clearance can allow levels to build up; this applies to all magnesium forms, not just threonate.
  • Pregnant or breastfeeding: not specifically studied for this form; the conservative position is to check with a clinician.

Interactions worth knowing about

  • Certain antibiotics (tetracyclines, quinolones) and bisphosphonates: magnesium can reduce absorption of these medications; the standard advice is to separate dosing by a few hours.
  • Other magnesium sources: effects are additive, so stacking multiple magnesium supplements (or a multivitamin plus a dedicated magnesium product) can push total elemental intake higher than intended.
If you take antibiotics, bisphosphonates, or have kidney impairment, check with a pharmacist before adding any magnesium supplement, threonate included.

Where the evidence is thin

  • Human cognitive-benefit data: small randomized trials only. A 2016 trial in older adults with cognitive complaints and a 2026 trial in adults aged 18–45 with poor sleep reported cognitive gains, but no independent group has replicated them, both were commercially funded (as was a 2024 sleep trial), and a publicly funded 2023 trial in patients after breast-cancer surgery found no significant cognitive difference from placebo.
  • Long-term safety at the studied dose: the cited cognition trials ran from 30 days to 12 weeks; multi-year data specific to this compound does not exist.
  • Healthy, younger adults: the 2026 trial enrolled adults aged 18–45 with sleep complaints, and a 2022 trial in healthy adults aged 18–65 tested a combination formula that also contained phosphatidylserine and vitamins, so neither tests magnesium L-threonate alone in the general population buying it as a nootropic.

How to think about it

Magnesium L-threonate's tolerability data is reassuring as far as it goes, but "as far as it goes" is a handful of small, commercially funded trials layered on top of a compelling rodent study. That is honestly a Grade C ingredient, not an established one: a reasonable pick for someone who specifically wants the brain-marketed form and has realistic expectations, but not a form to pay a premium for if your goal is simply adequate magnesium intake.

References

This article draws on the primary research below; see the linked studies for full methods and doses.

  • Slutsky I, Abumaria N, Wu LJ, et al. "Enhancement of learning and memory by elevating brain magnesium." Neuron, 2010;65(2):165–177. PMID: 20152124.
  • Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. "Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial." Journal of Alzheimer's Disease, 2016;49(4):971–990. PMID: 26519439.
  • Hausenblas HA, Lynch T, Hooper S, et al. "Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial." Sleep Medicine: X, 2024;8:100121. PMID: 39252819.
  • Lopresti AL, Smith SJ. "The effects of magnesium L-threonate (Magtein) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial." Frontiers in Nutrition, 2026;12:1729164. PMID: 41601871.
  • Zhang C, Hu Q, Li S, et al. "A Magtein®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults." Nutrients, 2022;14(24):5235. PMID: 36558392.
  • Ni Y, Deng F, Yu S, et al. "A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery." Breast Cancer: Targets and Therapy, 2023;15:495–504. PMID: 37520407.